Aurora Accountable Care Organization

ACO Name and Location

Aurora Accountable Care Organization LLC (AACO)
750 W. Virginia Street
Milwaukee Wisconsin 53204

ACO Primary Contact

Jacqueline Gisch, RN
aaco@aurora.org
(262) 787-2737

Organizational Information

  • ACO participants:
    1. Lakeshore Medical Clinic LLC
  • ACO participants in joint ventures between ACO professionals and hospitals:
    • None
  • ACO governing body:
    1. Patrick Falvey, Voting Member and Chair, AACO participant representative
    2. Sylvia Meltzer, MD, Voting Member and AACO President, AACO participant representative
    3. Sarang Baman, MD, Voting Member and AACO Medical Director, AACO participant
    4. Beverly Robinson, Voting Member, Medicare Beneficiary Representative
    5. Tom Zilavy, Voting Member and AACO Secretary, AACO participant representative
    6. Gary Hovila, Voting Member and AACO Treasurer, AACO participant representative
    7. Jackie Gisch, Voting Member and AACO Governing Board member, AACO participant representative
    8. Frank LaVora, MD, Voting Member and AACO Participant Physician
    9. Steve Francaviglia, Voting Member and AACO Governing Board member, AACO participant representative
    10. Amanpreet Sethi, MD, Voting member and AACO Governing Board member, AACO participant representative
  • Key ACO clinical and administrative leadership:
    1. Executive: Dr. Sylvia Meltzer
    2. Medical Director: Dr. Sarang Baman
    3. Compliance Officer: Sue Wong
    4. Quality Improvement Officer: Mary Kay Peterson
  • Associated committees and committee leadership:
    1. Management Committee: Scott Fenske MD, Chair
    2. Clinical and Service Quality Committee: Patrick Falvey, Co-Chair, John Konkel, MD, Co-Chair
    3. Compliance Committee: Sue Wong, Chair
  • Types of ACO participants, or combinations of participants, that formed the ACO:
    1. ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 79.9
ACO-2 CAHPS: How Well Your Providers Communicate N/A 92.63
ACO-3 CAHPS: Patients' Rating of Provider N/A 91.93
ACO-4 CAHPS: Access to Specialists N/A 83.52
ACO-5 CAHPS: Health Promotion and Education N/A 60
ACO-6 CAHPS: Shared Decision Making N/A 75.28
ACO-7 CAHPS: Health Status/Functional Status N/A 71.82
ACO-34 CAHPS: Stewardship of Patient Resources N/A 27.52
ACO-8 Risk-Standardized, All Condition Readmission N/A 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented N/A 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.